Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous versus oral tranexamic acid for shoulder arthroplasty
ACTRN12617000918325Phase 4Recruiting
- Sponsor
- Whangarei Hospital
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in osteoarthritis (OA) and shoulder arthritis (2 arms), sponsored by Whangarei Hospital. Primary endpoint: Change in hemoglobin. Started Aug 2017; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
osteoarthritis (OA)shoulder arthritis
Beyond the preview
Go deeper on ACTRN12617000918325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000918325.